Reference health

Community-associated meticillin-resistant Staphylococcus aureus

https://doi.org/10.1016/s0140-6736(09)61999-1
CiteStamped reference-health badge
1 of 145 checkable references need attention · checked 2026-08-03

At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.

10 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

References needing attention

does not resolve to a known work10.1128/MMBR.55.4.733-751.1991
The 144 checked references that resolve
resolves10.1086/320184
Survey of Infections Due to<i>Staphylococcus</i>Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999
resolves10.1086/533494
Changes in the Prevalence of Nasal Colonization with<i>Staphylococcus aureus</i>in the United States, 2001–2004
resolves10.1056/NEJM200101043440102
Nasal Carriage as a Source of<i>Staphylococcus aureus</i>Bacteremia
resolves10.1172/JCI38226
Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era
resolves10.1038/nrmicro2200
Waves of resistance: Staphylococcus aureus in the antibiotic era
resolves10.1126/science.99.2579.452
Extraction of a Highly Potent Penicillin Inactivator from Penicillin Resistant Staphylococci
resolves10.1136/bmj.1.5219.124-a
"Celbenin" - resistant Staphylococci
resolves10.1001/jama.298.15.1763
Invasive Methicillin-Resistant &lt;EMPH TYPE="ITAL"&gt;Staphylococcus aureus&lt;/EMPH&gt; Infections in the United States
resolves10.1001/jama.279.8.593
Community-Acquired Methicillin-Resistant &lt;EMPH TYPE="ITAL"&gt;Staphylococcus aureus&lt;/EMPH&gt; in Children With No Identified Predisposing Risk
resolves10.3201/eid0908.030089
Community-Acquired Methicillin-Resistant<i>Staphylococcus aureus</i>Carrying Panton-Valentine Leukocidin Genes: Worldwide Emergence
resolves10.3201/eid1304.061316
Global Distribution of Panton-Valentine Leukocidin–positive Methicillin-resistant<i>Staphylococcus aureus,</i>2006
resolves10.7326/0003-4819-97-3-325
Community-Acquired Methicillin-Resistant <i>Staphylococcus aureus</i> Infections: A New Source for Nosocomial Outbreaks
resolves10.1016/0195-6701(93)90100-E
Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia
resolves10.3201/eid1202.050454
Methicillin-resistant<i>Staphylococcus aureus</i>Clones, Western Australia
resolves10.1001/jama.282.12.1123
Four Pediatric Deaths From Community-Acquired Methicillin-Resistant Staphylococcus aureus--Minnesota and North Dakota, 1997-1999
resolves10.1016/S0140-6736(02)08713-5
Genome and virulence determinants of high virulence community-acquired MRSA
resolves10.1128/AAC.46.4.1147-1152.2002
Novel Type of Staphylococcal Cassette Chromosome <i>mec</i> Identified in Community-Acquired Methicillin-Resistant <i>Staphylococcus aureus</i> Strains
resolves10.1128/JCM.00245-07
The Emergence and Importation of Diverse Genotypes of Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) Harboring the Panton-Valentine Leukocidin Gene ( <i>pvl</i> ) Reveal that <i>pvl</i> Is a Poor Marker for Community-Acquired MRSA Strains in Ireland
resolves10.1128/JCM.42.7.3185-3190.2004
Diversity among Community Isolates of Methicillin-Resistant <i>Staphylococcus aureus</i> in Australia
resolves10.1093/jac/dkm309
A survey of community-associated methicillin-resistant Staphylococcus aureus in Korea
resolves10.1086/523763
Coexistence of Panton‐Valentine Leukocidin–Positive and –Negative Community‐Associated Methicillin‐Resistant<i>Staphylococcus aureus</i>USA400 Sibling Strains in a Large Canadian Health‐Care Region
resolves10.1128/JCM.41.11.5113-5120.2003
Pulsed-Field Gel Electrophoresis Typing of Oxacillin-Resistant<i>Staphylococcus aureus</i>Isolates from the United States: Establishing a National Database
resolves10.1128/JCM.38.3.1008-1015.2000
Multilocus Sequence Typing for Characterization of Methicillin-Resistant and Methicillin-Susceptible Clones of<i>Staphylococcus aureus</i>
resolves10.3201/eid1209.051634
Shift in<i>Staphylococcus aureus</i>Clone Linked to an Infected Tattoo
resolves10.1016/S1473-3099(06)70491-1
Meticillin-resistant Staphylococcus aureus among US prisoners and military personnel: review and recommendations for future studies
resolves10.1086/517478
Methicillin-Resistant Staphylococcus aureus in Two Child Care Centers
resolves10.7326/0003-4819-148-4-200802190-00204
Emergence of Multidrug-Resistant, Community-Associated, Methicillin-Resistant <i>Staphylococcus aureus</i> Clone USA300 in Men Who Have Sex with Men
resolves10.1086/425313
A High-Morbidity Outbreak of Methicillin-Resistant Staphylococcus aureus among Players on a College Football Team, Facilitated by Cosmetic Body Shaving and Turf Burns
resolves10.1086/383247
Community‐Onset Methicillin‐Resistant<i>Staphylococcus aureus</i>Associated with Antibiotic Use and the Cytotoxin Panton‐Valentine Leukocidin during a Furunculosis Outbreak in Rural Alaska
resolves10.1086/526773
Colonization, Fomites, and Virulence: Rethinking the Pathogenesis of Community-Associated Methicillin-Resistant Staphylococcus aureus Infection
resolves10.1073/pnas.0710217105
Epidemic community-associated methicillin-resistant <i>Staphylococcus aureus</i> : Recent clonal expansion and diversification
resolves10.1056/NEJMoa055356
Methicillin-Resistant <i>S. aureus</i> Infections among Patients in the Emergency Department
resolves10.1111/j.1469-0691.2005.01173.x
Methicillin-resistant Staphylococcus aureus producing Panton–Valentine leukocidin in a retrospective case series from 12 French hospital laboratories, 2000–2003
resolves10.1111/j.1365-2133.2005.06910.x
Emergence of two populations of methicillin-resistant <i>Staphylococcus aureus</i> with distinct epidemiological, clinical and biological features, isolated from patients with community-acquired skin infections
resolves10.1128/JCM.37.11.3556-3563.1999
Evaluation of Protein A Gene Polymorphic Region DNA Sequencing for Typing of<i>Staphylococcus aureus</i>Strains
resolves10.1073/pnas.122108599
The evolutionary history of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA)
resolves10.1086/344326
A Novel Methicillin‐Resistance Cassette in Community‐Acquired Methicillin‐Resistant<i>Staphylococcus aureus</i>Isolates of Diverse Genetic Backgrounds
resolves10.1128/AAC.01239-06
Fitness Cost of Staphylococcal Cassette Chromosome <i>mec</i> in Methicillin-Resistant <i>Staphylococcus aureus</i> by Way of Continuous Culture
resolves10.1128/JCM.40.11.4289-4294.2002
Dissemination of New Methicillin-Resistant <i>Staphylococcus aureus</i> Clones in the Community
resolves10.1086/587907
The Arginine Catabolic Mobile Element and Staphylococcal Chromosomal Cassette<i>mec</i>Linkage: Convergence of Virulence and Resistance in the USA300 Clone of Methicillin‐Resistant<i>Staphylococcus aureus</i>
resolves10.1128/AAC.00629-06
Redefining a Structural Variant of Staphylococcal Cassette Chromosome <i>mec</i> , SCC <i>mec</i> Type VI
resolves10.1016/j.bbrc.2008.10.009
Structure and specific detection of staphylococcal cassette chromosome mec type VII
resolves10.1128/AAC.01118-08
Novel Staphylococcal Cassette Chromosome <i>mec</i> Type, Tentatively Designated Type VIII, Harboring Class A <i>mec</i> and Type 4 <i>ccr</i> Gene Complexes in a Canadian Epidemic Strain of Methicillin-Resistant <i>Staphylococcus aureus</i>
resolves10.7326/0003-4819-144-5-200603070-00006
A U.S. Population-Based Survey of <i>Staphylococcus aureus</i> Colonization
resolves10.1128/CMR.10.3.505
Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks
resolves10.1086/315695
Prevalence of Methicillin‐Resistant and Methicillin‐Susceptible<i>Staphylococcus aureus</i>in the Community
resolves10.1097/00006454-199905000-00003
Methicillin-resistant and borderline methicillin-resistant asymptomatic Staphylococcus aureus colonization in children without identifiable risk factors
resolves10.1097/01.inf.0000168746.62226.a4
Increasing Rates of Nasal Carriage of Methicillin-Resistant Staphylococcus aureus in Healthy Children
resolves10.1016/j.amjmed.2006.01.004
Fifteen-Year Study of the Changing Epidemiology of Methicillin-Resistant Staphylococcus aureus
resolves10.1056/NEJMoa042859
A Clone of Methicillin-Resistant<i>Staphylococcus aureus</i>among Professional Football Players
resolves10.3201/eid1104.041094
MRSA outbreak was controlled with daily hexachlorophene showers and hygiene education.
resolves10.1086/430312
Three-Year Surveillance of Community-AcquiredStaphylococcus aureus Infections in Children
resolves10.1086/589717
<i>Staphylococcus aureus</i>Bloodstream Infections: Risk Factors, Outcomes, and the Influence of Methicillin Resistance in Calgary, Canada, 2000–2006
resolves10.1097/01.qai.0000179464.40948.b9
Incidence of and Risk Factors for Clinically Significant Methicillin-Resistant Staphylococcus aureus Infection in a Cohort of HIV-Infected Adults
resolves10.1001/archpedi.159.10.980
Epidemic of Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections
resolves10.1056/NEJMoa043252
Methicillin-Resistant<i>Staphylococcus aureus</i>Disease in Three Communities
resolves10.1086/587893
A Population‐Based Study of the Incidence and Molecular Epidemiology of Methicillin‐Resistant<i>Staphylococcus aureus</i>Disease in San Francisco, 2004–2005
resolves10.1056/NEJMoa044194
<i>Staphylococcus aureus</i>Sepsis and the Waterhouse–Friderichsen Syndrome in Children
resolves10.1086/428573
Purpura Fulminans Due to<i>Staphylococcus aureus</i>
resolves10.1086/507637
Infective Pyomyositis and Myositis in Children in the Era of Community‐Acquired, Methicillin‐Resistant<i>Staphylococcus aureus</i>Infection
resolves10.1056/NEJMoa042683
Necrotizing Fasciitis Caused by Community-Associated Methicillin-Resistant<i>Staphylococcus aureus</i>in Los Angeles
resolves10.1097/01.bpo.0000242431.91489.b4
Changing Patterns of Acute Hematogenous Osteomyelitis and Septic Arthritis
resolves10.3201/eid1110.050141
Community-associated Methicillin-resistant<i>Staphylococcus aureus</i>, Minnesota, 2000–2003
resolves10.1086/427148
Severe Community-Onset Pneumonia in Healthy Adults Caused by Methicillin-Resistant Staphylococcus aureus Carrying the Panton-Valentine Leukocidin Genes
resolves10.1086/432475
Pulmonary Manifestations in Children with Invasive Community-Acquired Staphylococcus aureus Infection
resolves10.3201/eid1206.051141
Severe Community-acquired Pneumonia Due to<i>Staphylococcus aureus</i>, 2003–04 Influenza Season
resolves10.1001/jama.290.22.2976
Comparison of Community- and Health Care–Associated Methicillin-Resistant &lt;EMPH TYPE="ITAL"&gt;Staphylococcus aureus&lt;/EMPH&gt; Infection
resolves10.1016/j.idc.2008.10.003
Host Defense and Pathogenesis in Staphylococcus aureus Infections
resolves10.1016/j.molimm.2006.06.011
Bacterial complement evasion
resolves10.2217/17460913.3.4.437
<i>Staphylococcus Aureus</i> Evasion of Innate Antimicrobial Defense
resolves10.1038/nrmicro1289
Immune evasion by staphylococci
resolves10.1073/pnas.0900743106
Evolution of virulence in epidemic community-associated methicillin-resistant <i>Staphylococcus aureus</i>
resolves10.4049/jimmunol.175.6.3907
Insights into Mechanisms Used by <i>Staphylococcus aureus</i> to Avoid Destruction by Human Neutrophils
resolves10.1016/S0934-8840(99)80105-4
Leukocidal Toxins of Staphylococci
resolves10.1371/journal.pone.0006387
Staphylococcus aureus Panton-Valentine Leukocidin Contributes to Inflammation and Muscle Tissue Injury
resolves10.1371/journal.pone.0003198
Contribution of Panton-Valentine Leukocidin in Community-Associated Methicillin-Resistant Staphylococcus aureus Pathogenesis
resolves10.1128/IAI.00021-09
Transcription of Inflammatory Genes in the Lung after Infection with Community-Associated Methicillin-Resistant <i>Staphylococcus aureus</i> : a Role for Panton-Valentine Leukocidin?
resolves10.1086/509506
Is Panton‐Valentine Leukocidin the Major Virulence Determinant in Community‐Associated Methicillin‐Resistant <i>Staphylococcus aureus</i> Disease?
resolves10.1038/nm1207-1405
Poring over pores: α-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia
resolves10.1086/592053
Panton‐Valentine Leukocidin Is Not a Virulence Determinant in Murine Models of Community‐Associated Methicillin‐Resistant<i>Staphylococcus aureus</i>Disease
resolves10.1111/j.1469-0691.2008.02648.x
The Panton–Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300
resolves10.1126/science.1137165
<i>Staphylococcus aureus</i> Panton-Valentine Leukocidin Causes Necrotizing Pneumonia
resolves10.1086/604728
A Point Mutation in the<i>agr</i>Locus rather than Expression of the Panton‐Valentine Leukocidin Caused Previously Reported Phenotypes in<i>Staphylococcus aureus</i>Pneumonia and Gene Regulation
resolves10.1086/605332
Phenol‐Soluble Modulin α3 Enhances the Human Neutrophil Lysis Mediated by Panton‐Valentine Leukocidin
resolves10.1002/path.1700910237
Reaction of rabbit leucocytes to staphylococcal (Panton‐Valentine) leucocidin <i>in vivo</i>
resolves10.1371/journal.pone.0007204
Panton–Valentine Leukocidin Enhances the Severity of Community-Associated Methicillin-Resistant Staphylococcus aureus Rabbit Osteomyelitis
resolves10.1016/S0140-6736(02)07877-7
Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients
resolves10.1038/nm1656
Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA
resolves10.1073/pnas.94.21.11607
Transmembrane β-barrel of staphylococcal α-toxin forms in sensitive but not in resistant cells
resolves10.1086/592758
α‐Toxin Facilitates the Generation of CXC Chemokine Gradients and Stimulates Neutrophil Homing in<i>Staphylococcus aureus</i>Pneumonia
resolves10.1084/jem.20072208
Vaccine protection against <i>Staphylococcus aureus</i> pneumonia
resolves10.1016/j.mib.2004.04.002
Analyses of clonality and the evolution of bacterial pathogens
resolves10.1086/590157
Comparison of Virulence in Community‐Associated Methicillin‐Resistant<i>Staphylococcus aureus</i>Pulsotypes USA300 and USA400 in a Rat Model of Pneumonia
resolves10.1016/S0140-6736(06)68231-7
Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus
resolves10.1128/JCM.01557-08
Emergence and Characterization of Community-Associated Methicillin-Resistant <i>Staphyloccocus aureus</i> Infections in Denmark, 1999 to 2006
resolves10.1128/JCM.43.9.4719-4730.2005
Successful Multiresistant Community-Associated Methicillin-Resistant <i>Staphylococcus aureus</i> Lineage from Taipei, Taiwan, That Carries Either the Novel Staphylococcal Chromosome Cassette <i>mec</i> (SCC <i>mec</i> ) Type V <sub>T</sub> or SCC <i>mec</i> Type IV
resolves10.1016/S0958-1669(00)00155-5
Bacterial virulence as a target for antimicrobial chemotherapy
resolves10.1002/med.20160
Looking toward basic science for potential drug discovery targets against community‐associated MRSA
resolves10.1128/AAC.00447-08
Detection of Staphylococcal Cassette Chromosome <i>mec</i> -Associated DNA Segments in Multiresistant Methicillin-Susceptible <i>Staphylococcus aureus</i> (MSSA) and Identification of <i>Staphylococcus epidermidis ccrAB4</i> in both Methicillin-Resistant <i>S. aureus</i> and MSSA
resolves10.1128/JCM.00139-07
Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) Detection: Comparison of Two Molecular Methods (IDI-MRSA PCR Assay and GenoType MRSA Direct PCR Assay) with Three Selective MRSA Agars (MRSA ID, MRSA <i>Select</i> , and CHROMagar MRSA) for Use with Infection-Control Swabs
resolves10.1111/j.1365-2672.2004.02470.x
Evaluation of six commercial identification kits for the identification of Staphylococcus aureus isolated from bovine mastitis
resolves10.1097/01.inf.0000109288.06912.21
Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus
resolves10.1016/S0196-0644(85)80727-7
Treatment of cutaneous abscess: A double-blind clinical study
resolves10.1128/AAC.00377-07
Randomized, Double-Blind, Placebo-Controlled Trial of Cephalexin for Treatment of Uncomplicated Skin Abscesses in a Population at Risk for Community-Acquired Methicillin-Resistant <i>Staphylococcus aureus</i> Infection
resolves10.1086/497143
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
resolves10.1093/jac/dkn096
Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community
resolves10.1155/2006/402361
Guidelines for the Prevention and Management of Community‐Associated Methicillin‐Resistant <i>Staphylococcus aureus</i>: A Perspective for Canadian Health Care Practitioners
resolves10.1097/00006454-200206000-00010
Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children
resolves10.1097/01.inf.0000073163.37519.ee
Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children
resolves10.1097/01.inf.0000171175.76673.64
Increasing Clindamycin Resistance Among Methicillin-Resistant Staphylococcus aureus in 57 Northeast United States Military Treatment Facilities
resolves10.1097/01.inf.0000207404.50143.1e
Three-Year Surveillance of Community Onset Health Care-Associated Staphylococcus aureus Infections in Children
resolves10.1128/AAC.6.4.411
Activity of Tetracycline, Doxycycline, and Minocycline Against Methicillin-Susceptible and -Resistant Staphylococci
resolves10.1128/AAC.00262-07
Tetracyclines as an Oral Treatment Option for Patients with Community Onset Skin and Soft Tissue Infections Caused by Methicillin-Resistant<i>Staphylococcus aureus</i>
resolves10.1086/429628
Use of Long-Acting Tetracyclines for Methicillin-Resistant Staphylococcus aureus Infections: Case Series and Review of the Literature
resolves10.1128/AAC.00206-07
Prospective Randomized Trial of Empiric Therapy with Trimethoprim-Sulfamethoxazole or Doxycycline for Outpatient Skin and Soft Tissue Infections in an Area of High Prevalence of Methicillin-Resistant <i>Staphylococcus aureus</i>
resolves10.7326/0003-4819-117-5-390
Trimethoprim-Sulfamethoxazole Compared with Vancomycin for the Treatment of <i>Staphylococcus aureus</i> Infection
resolves10.1086/525536
Role of Folate Antagonists in the Treatment of Methicillin-Resistant Staphylococcus aureus Infection
resolves10.1128/AAC.01244-06
Treatment and Outcomes of Infections by Methicillin-Resistant <i>Staphylococcus aureus</i> at an Ambulatory Clinic
resolves10.1086/499365
Dumb and Dumber--The Potential Waste of a Useful Antistaphylococcal Agent: Emerging Fusidic Acid Resistance in Staphylococcus aureus
resolves10.1086/318486
Linezolid (PNU-100766) versus Vancomycin in the Treatment of Hospitalized Patients with Nosocomial Pneumonia: A Randomized, Double-Blind, Multicenter Study
resolves10.1086/340353
Linezolid versus Vancomycin for the Treatment of Methicillin‐Resistant <i>Staphylococcus aureus</i> Infections
resolves10.1128/AAC.49.6.2260-2266.2005
Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue Infections
resolves10.1016/S0149-2918(03)80118-2
Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia
resolves10.1056/NEJM200301023480123
Linezolid-Induced Lactic Acidosis
resolves10.1086/501356
Linezolid-Induced Inhibition of Mitochondrial Protein Synthesis
resolves10.1128/AAC.46.8.2723-2726.2002
Hematologic Effects of Linezolid: Summary of Clinical Experience
resolves10.1001/archinte.167.17.1861
Persistent Staphylococcus aureus Bacteremia&lt;subtitle&gt;An Analysis of Risk Factors and Outcomes&lt;/subtitle&gt;
resolves10.1016/j.jinf.2008.04.003
Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infections
resolves10.1128/AAC.01602-07
Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity
resolves10.1093/jac/dkm258
Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001 05
resolves10.1128/JCM.01388-06
Increased Vancomycin MICs for <i>Staphylococcus aureus</i> Clinical Isolates from a University Hospital during a 5-Year Period
resolves10.1086/519471
Alternatives to Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections
resolves10.2174/157489108783413173
Registered and Investigational Drugs for the Treatment of Methicillin-Resistant Staphylococcus aureus Infection
resolves10.1086/533593
Skin and Soft‐Tissue Infections Caused by Community‐Acquired Methicillin‐Resistant<i>Staphylococcus aureus</i>
resolves10.1128/AAC.49.3.884-888.2005
Evaluation of Ceftobiprole in a Rabbit Model of Aortic Valve Endocarditis Due to Methicillin-Resistant and Vancomycin-Intermediate <i>Staphylococcus aureus</i>
resolves10.1128/AAC.01242-06
In Vivo Efficacy of Ceftaroline (PPI-0903), a New Broad-Spectrum Cephalosporin, Compared with Linezolid and Vancomycin against Methicillin-Resistant and Vancomycin-Intermediate <i>Staphylococcus aureus</i> in a Rabbit Endocarditis Model
resolves10.1128/AAC.00551-07
Results of a Double-Blind, Randomized Trial of Ceftobiprole Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria
resolves10.1128/AAC.00859-08
In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains
resolves10.1076/ceyr.22.6.451.5486
Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit
resolves10.2174/138955707782795638
Two-Peptide Lantibiotics: A Medical Perspective
resolves10.1099/mic.0.2007/007807-0
The β-lactam-resistance modifier (−)-epicatechin gallate alters the architecture of the cell wall of Staphylococcus aureus
resolves10.1016/j.ijantimicag.2008.06.009
Vaccination and passive immunisation against Staphylococcus aureus
resolves10.1056/NEJMoa011297
Use of a<i>Staphylococcus aureus</i>Conjugate Vaccine in Patients Receiving Hemodialysis
resolves10.1084/jem.95.2.209
THE SURVIVAL OF STAPHYLOCOCCI WITHIN HUMAN LEUKOCYTES
The 10 references without a DOI — listed, not checked
no DOI — not checkedInfections caused by a particular phage type of Staphylococcus aureus
no DOI — not checkedCommunity-associated methicillin-resistant Staphylococcus aureus infections in Pacific Islanders—Hawaii. 2001–2003. MMWR Morb Mortal Wkly Rep 2004; 53: 767–70.
no DOI — not checkedMethicillin-resistant Staphylococcus aureus infections among competitive sports participants—Colorado, Indiana, Pennsylvania, and Los Angeles County. 2000–2003
no DOI — not checkedStaphylococcal leukocidin
no DOI — not checkedEffect of staphylococcal leukocidin on mouse leukocyte system
no DOI — not checkedDiep BA, ChanL, Tattevin P. et al., Panton-Valentine leukocidin determines the virulence of USA300 methicillin-resistant Staphylococcus aureus in a rabbit model of fulminant necrotizing, hemorrhagic pneumonia. 49th ICAAC, San Francisco, CA, Sept 12–15, 2009 (abstr B-1087).
no DOI — not checkedRandomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient
no DOI — not checkedGorwitz RJ, Jernigan DB, Powers JH, Jernigan JA, and Participants in the Centers for Disease Control and Prevention-Convened Experts' Meeting on Management of MRSA in the Community. Strategies for clinical management of MRSA in the community: summary of an experts' meeting convened by the Centers for Disease Control and Prevention. 2006. Available at http://www.cdc.gov/ncidod/dhqp/pdf/ar/CAMRSA_ExpMtgStrategies.pdf.
no DOI — not checkedPersistent Staphylococcus aureus bacteremia: incidence and outcome trends over time
no DOI — not checkedCeftaroline fosamil, a cephalosporin derivative for the potential treatment of MRSA infection
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-08-03 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

view as graph · paper page

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/s0140-6736(09)61999-1"><img src="https://citestamp.com/citestamped/10.1016/s0140-6736(09)61999-1/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/s0140-6736(09)61999-1/badge.svg)](https://citestamp.com/citestamped/10.1016/s0140-6736(09)61999-1)